Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

by | Jul 9, 2026 | Clinical Trials | 0 comments

​ Conditions: Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma; Becotatug Vedotin; Pucotenlimab

Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Pucotenlimab

Sponsors: West China Second University Hospital

Not yet recruiting Conditions: Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma; Becotatug Vedotin; Pucotenlimab
Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Pucotenlimab
Sponsors: West China Second University Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *